Monopar Therapeutics Inc. (MNPR) Financials
MNPR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 135.0 million | 4.1 million |
| March 31, 2026 | 138.0 million | 2.6 million |
| Dec. 31, 2025 | 140.7 million | 2.9 million |
| Sept. 30, 2025 | 144.2 million | 2.6 million |
MNPR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -3.2 billion | 1.4 billion |
| March 31, 2026 | -3.5 million | 1.7 million |
| Dec. 31, 2025 | -3.4 million | 1.1 million |
| Sept. 30, 2025 | -2.1 million | 1.1 million |
MNPR Net Income
No data available :(
MNPR Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 134.3 million | - | 107829 |
| March 31, 2026 | 137.5 million | - | 131565 |
| Dec. 31, 2025 | 140.4 million | - | 154920 |
| Sept. 30, 2025 | 143.7 million | - | 102236 |
MNPR Shares Outstanding
MNPR Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 4 | 4.8 million | 1.9 million | - |
| March 31, 2026 | 4 | 3.5 million | 1.7 billion | - |
| Dec. 31, 2025 | - | 3.9 million | 2.2 million | - |
| Sept. 30, 2025 | 2 | 2.6 million | 1.5 million | - |
MNPR Cost of Revenue
No data available :(
MNPR
Price: $69.27
52 week price:
Earnings Per Share: -2.26 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 123422
Market Capitalization: 522.3 million